Relay Therapeutics
CIK 0001812364 · Biotech · Public
Motion-based drug discovery platform that designs protein inhibitors by modeling dynamic protein conformations
relaytx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $30M
- 1 Form D · Jan 2024
- 33 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 3 granted · 37 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $30,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2300 | Retrotope, Inc. | — | $32M |
| 2301 | Basking Biosciences | — | $29M |
| 2302 | GALATEA BIO INC | — | $3.7M |
| 2303 | Relay Therapeutics | — | $30M |
| 2304 | Acurx Pharmaceuticals, Inc. | — | $17M |
| 2305 | Congruence Therapeutics | — | — |
| 2306 | BICYCLE THERAPEUTICS PLC | — | $555M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Brian AdamsExecutive Officer
- Donald BergstromExecutive Officer
- Alexis BorisyDirector
- Thomas CatinazzoExecutive Officer
- Linda HillDirector
- Douglas IngramDirector
- Sekar KathiresanDirector
- Mark MurckoDirector
- Sanjiv PatelDirector · Executive Officer
- Peter RahmerExecutive Officer
- Jami RubinDirector
- Laura ShawverDirector
Patents
- Cdk Inhibitors And Methods Of Use Thereofapplication
- Bifunctional PI3K-ALPHA Inhibitors And Uses Thereofapplication
- PI3K-ALPHA Inhibitors And Methods Of Making And Using The Sameapplication
- Solid Forms Of A Cdk Inhibitorapplication
- PI3K-ALPHA Inhibitors And Methods Of Use Thereofapplication
- Estrogen Receptor Alpha Degraders And Methods Of Use Thereofapplication
- PI3K-ALPHA Inhibitors And Methods Of Use Thereofapplication
- Fgfr Inhibitors And Methods Of Making And Using The Sameapplication
- PI3K-ALPHA Inhibitors And Methods Of Use Thereofapplication
- PI3K-ALPHA Inhibitors And Methods Of Use Thereofapplication
- Fgfr Inhibitors And Methods Of Making And Using The Samegranted
- JAK2 Inhibitors And Methods Of Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.